Ovarian Needle Puncture for Follicle Activation in IVF Patients With Diminished Ovarian Reserve
NCT04608695 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2022-09-21
Summary
Premature ovarian insufficiency (POI), is cessation of ovarian function characterized by hypergonadotropic amenorrhea and hypoestrogenic syndrome before 40 years of age. About 1% of women younger than 40 years old and 0.1% before 30 are affected. POI imposes a great challenge on women's reproductive and long-term health, such as infertility, amenorrhea, osteoporosis, and cardiovascular disease. Most patients already had impaired or complete loss of fecundity when diagnosed. Currently, no optimal regimen exists to ameliorate ovarian function. Typically, they end up with egg donation or adoption as an alternative way. Less severe form of POI is diminished ovarian reserve (DOR). Although lack of consensus according to Bologna criteria cut off for DOR was defined as (antral follicle count (AFC) \<5-7 follicles or anti-Mullerian hormone (AMH) \<0.5-1.1 ng/ml).
Previously it has been showed that 24% of women with POI had resumption of ovarian function and 4% resulted in baby births. These data indicates residual follicles are available in atrophic ovaries and have potential for development and even fertilization. In routine IVF practice 15% percent of patients have poor ovarian response to ovarian stimulation. Patients with DOR with a previous poor ovarian response (cycles cancelled or yielding ≤3 oocytes with a conventional protocol) might have benefit from the strategies increasing follicle activation and number of growing follicles and oocyte retrieved. Therefore, strategies enabling ovarian resumption predictable and follicle activation feasible are promising for POI/DOR treatment. Recently, In vitro Activation (IVA) approach has been proposed and live births have been achieved in patients with POI. Phosphatase and tensin homolog (PTEN) enzyme inhibitors and phosphatidylinositol-3 kinase activators could activate AKT pathway and activate the dormant follicles. Ovarian fragmentation could lead to ovarian primary follicle growth by interfering with Hippo signaling pathway. Residual follicles in patients with POI could be activated to develop for egg retrieval by combination of mechanical and chemical stimulation.
In 2019, Zhang et al retrospectively analyzed the follicle development and pregnancy outcome in 80 POI patients after laparoscopic ovarian biopsy/scratch without using chemical agents as was the case in IVA. 11 (13.75%) patients presented with ovarian function resumption, three metaphases II oocytes were retrieved in 10 patients and two embryos were formed and freshly transferred followed by a healthy singleton delivery in 1 (1.25%) patient. They concluded that the technique of ovarian biopsy/scratch without chemical activation could promote follicle development in vivo, suggesting it could bring promising benefits for some women with POI.
In patient with POI/DOR, activation of residual follicles is a promising option and further studies are warranted. Previous studies included laparoscopic surgery which may lead to possible surgical complications. Without using chemical agents and laparoscopic surgery, main object of this study is mechanical follicle activation with trans-vaginal ovarian needle puncture with 17 gauge oocyte pickup needle in IVF patients with DOR.
Conditions
- Activation of Primordial Follicles
Interventions
- PROCEDURE
-
Ovarian puncture
One side ovary of each patient included in the study, will be punctured 10 times under trans-vaginal ultrasound guidance with 17 gauge ovarian pick up needle, 1 month before the scheduled IVF cycle. Control group will be the other side ovary for each patient. Number of ≥ 14 mm follicle and collected oocytes will be compared.
Sponsors & Collaborators
-
Hacettepe University
lead OTHER
Principal Investigators
-
Sezcan Mumusoğlu, Assoc. Prof. · Hacettepe University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2023-07-01
- Completion
- 2023-09-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Establishing of an Early Warming System of Premature Ovarian Insufficiency
NCT03518944 ·Status: UNKNOWN
-
Acupuncture for Treatment of Patients With Poor Ovarian Response
NCT04013984 ·Status: COMPLETED ·Phase: NA
-
Ovarian Tissue Allo-transplantation
NCT06673004 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
NCT05308342 ·Status: UNKNOWN ·Phase: NA
-
Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure
NCT02043743 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
In Vitro Follicle Activation in Patient With Premature Ovarian Failure Under 36 Years Old
NCT04131244 ·Status: COMPLETED ·Phase: NA
-
Treatment of Premature Ovarian Insufficiency Using Bone Marrow Cells
NCT06302543 ·Status: RECRUITING ·Phase: NA
-
Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)
NCT02603744 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure
NCT02062931 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
NCT01742533 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve
NCT06048666 ·Status: UNKNOWN ·Phase: PHASE3
-
Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)
NCT03069209 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Amniotic Epithelial Cells Treatment for Ovarian Insufficiency
NCT03207412 ·Status: UNKNOWN ·Phase: NA
-
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients
NCT04031456 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Autologous ADMSC Transplantation in Patients With POI
NCT06132542 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Evaluation on Biological Characteristics of Acupoints in Premature Ovarian Insufficiency
NCT06145061 ·Status: RECRUITING
-
Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure
NCT06202547 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve
NCT02240342 ·Status: UNKNOWN ·Phase: NA
-
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
NCT06481969 ·Status: RECRUITING ·Phase: NA
-
Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.
NCT04588844 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency
NCT03816852 ·Status: SUSPENDED ·Phase: PHASE2
-
Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)
NCT03033277 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Calcium Ionophore Solution Can Increase Fertilization Rate in Patients During Intracytoplasmic Sperm Injection(ICSI) Who Have Poor Ovarian Reserve?
NCT02045914 ·Status: UNKNOWN ·Phase: NA
-
Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients
NCT03080584 ·Status: UNKNOWN ·Phase: NA
-
Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes
NCT06841328 ·Status: RECRUITING